|
Prevalence of enteropathogens among the studied populations. |
||
| Enteropathogen |
Patient group (%) n = 300 |
Control group (%) n = 80 |
|
|
||
| Entamoeba histolytica/Entamoeba dispar |
211 (70.3) |
35 (43.7) |
| Giardia intestinalis |
99 (33.0) |
16 (20.0) |
| Salmonella ohio |
85 (28.3) |
2 (2.5) |
| Salmonella typhimurium |
49 (16.3) |
1 (1.2) |
| ETEC |
40 (13.3) |
2 (2.5) |
| EPEC |
28 (9.3) |
1 (1.2) |
| Salmonella infantis |
24 (8.0) |
0 |
| VTEC |
26 (8.6) |
1(1.2) |
| Shigella flexneri |
5 (1.6) |
0 |
| Shigella sonnei |
3 (1.0) |
0 |
| EIEC |
3 (1.0) |
0 |
| Salmonella anatum |
2 (0.6) |
0 |
| Salmonella Newport |
1 (0.3) |
0 |
|
ETEC, enterotoxigenic E. coli; EPEC, enteropathogenic E. coli; VTEC, verotoxigenic E. coli; EIEC, enteroinvasive E. coli. | ||
Paniagua et al. Annals of Clinical Microbiology and Antimicrobials 2007 6:17 doi:10.1186/1476-0711-6-17 |
||